Clinical trial · Interventional
Development of Clinical and Biological Database in Colorectal Cancer
Clinical and Biological Evaluation to Caracterize Circulating Tumoral Cells in Colorectal Cancer
NCT04186117CI-TRIAL-00085815CIRCUScompletedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Creation of circulating cancer cell-lines and caracterisation of these cell-lines which will be collected before any treatment in patients with metastatic colon adenocarcinoma
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Metastatic Colon Cancer | Malignant Colon Neoplasm | CURATED_BROADER | 0.78 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Blood sample | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Biological collection
- description
- For all the patients include in the study : \- Blood samples collected at before any treatment In parallel to this biological collection, standardized clinical data will be entered into a database
- interventionNames
- Other: Blood sample
Primary outcomes (1)
- measure
- Isolation of circulating tumoral cells
- timeFrame
- Until the study completion : 54 months
- description
- among 100 patients, to isolate at least 10 cell-lines to show the heterogeneity between patients
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Male or female ≥ 18 years * Histological evidence of metastatic colorectal cancer * Naïve patients receiving chemotherapy at the metastatic stage or who have received adjuvant chemotherapy for more than 6 months * Obtain signed informed consent prior to any specific preselection procedure. Exclusion Criteria: * History of Chemotherapy Treatment and / or Targeted Therapy for Metastatic Colorectal Cancer * Breastfeeding or pregnant woman * Patient whose regular follow-up is impossible for psychological, family, social or geographical reasons * Any severe or unstable medical, psychiatric or other condition that may interfere with the patient's safety, consent or compliance with the study protocol * Patient not benefiting from a social security scheme
References
Publications (0)
Data not yet available
No reference posted for this study.